Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Insulin Resistance 2Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ketosis 1Glioma 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 35Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Biguanides × Clear all
NCT00948402 2009-10-14

PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives

Federico II University

Phase 3 Completed
20 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡